Edition:
United States

Active Biotech AB (ACTI.ST)

ACTI.ST on Stockholm Stock Exchange

5.35SEK
11:29am EDT
Change (% chg)

-0.05kr (-0.93%)
Prev Close
5.40kr
Open
5.40kr
Day's High
5.50kr
Day's Low
5.15kr
Volume
170,261
Avg. Vol
514,783
52-wk High
21.90kr
52-wk Low
4.17kr

ACTI.ST

Chart for ACTI.ST

About

Active Biotech AB is a Sweden-based company that focuses on pharmaceutical research and development in medical fields in which the immune system plays a central role. The Company’s research portfolio primarily includes projects for the development of drugs for the treatment of autoimmune and inflammatory diseases and cancer. As... (more)
No analyst recommendations are available for ACTI.ST.

Overall

Beta: 2.71
Market Cap(Mil.): kr522.85
Shares Outstanding(Mil.): 96.82
Dividend: --
Yield (%): --

Financials

  ACTI.ST Industry Sector
P/E (TTM): -- 137.90 17.41
EPS (TTM): -0.63 -- --
ROI: -15.44 -8.48 -5.42
ROE: -34.99 -11.31 -4.68

BRIEF-Active Biotech: FDA grants Orphan Drug Designation for tasquinimod for multiple myeloma treatment

* Reg-Active biotech: fda grants orphan drug designation for tasquinimod for the treatment of multiple myeloma Source text for Eikon: Further company coverage: (Reporting By Anna Ringstrom)

Apr 12 2017

BRIEF-Active Biotech Q4 operating loss narrows to SEK 13.5 mln

* Q4 net sales SEK 7.1 million versus SEK 5.0 million year ago

Feb 16 2017

BRIEF-Active Biotech says receives European patent for tasquinimod

* Says the European Patent Office grants patent for tasquinimod for treatment of multiple myeloma

Jan 09 2017

More From Around the Web

Earnings vs. Estimates